优化阿里皮拉单治疗:长效注射配方的药理学优势,一个共识小组报告
Joseph F Goldberg1, Eric D Achtyes2, Christoph U Correll3,4,5
1Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York.
长效注射性阿里皮普拉是一种部分多巴胺激动剂,可以改善精神分裂症和双相I型精神障碍 (BP-I) 的坚持和结果. 每两个月一次的配方为这些慢性疾病提供了增强的临床效用.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 精神分裂症和双相I型精神障碍 (BP-I) 是严重的精神疾病,具有显著的发病率和死亡率.
- 对口服抗精神病药物的不良坚持使功能衰退和结果恶化.
- 长效注射 (LAI) 抗精神病药物解决了坚持问题,改善了患者的治疗结果.
研究的目的:
- 评估阿里皮普拉单一水合物LAI的药理动力学特性,安全性,疗效和临床实用性.
- 专注于每两个月一次用于精神分裂症和BP-I的准备使用的配方.
- 为优化LAI在临床实践中的使用提供指导.
主要方法:
- 由五名精神病专家组成的共识小组.
- 对阿里皮普拉单一水合剂的药理动力学,安全性和疗效数据的审查.
- 临床功效的评估,特别是2个月制剂.
主要成果:
- 阿里皮普拉LAI提供了一个独特的局部多巴胺激动因子配置.
- 证明的好处包括减少不坚持,复发和住院治疗.
- 改善功能,改善生活质量和降低死亡风险与LAI使用有关.
结论:
- 阿里皮普拉单酸的LAI是精神分裂症和BP-I的有价值的治疗选择.
- 每两个月一次的配方提高了方便性和坚持性.
- 优化LAI的使用可以显著改善严重精神疾病患者的结果.
更多相关视频
07:49Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions
Published on: September 17, 2014
07:28Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
相关概念视频
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Biopharmaceutics and Pharmacokinetics: Overview
Drug Therapy
Antianxiety Medications
Routes of Drug Administration: Parenteral
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
Psychosis: Goals of Pharmacotherapy
Additional Routes of Drug Administration
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
